The long-term efficacy and safety of fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®) in diabetic macular oedema in a multi-ethnic inner-city population

MLA

Panos, Georgios D., et al. “The Long-Term Efficacy and Safety of Fluocinolone Acetonide Intravitreal Implant 190 Μg (ILUVIEN®) in Diabetic Macular Oedema in a Multi-Ethnic Inner-City Population.” European Journal of Ophthalmology, vol. 31, no. 2, Mar. 2021, pp. 620–29. EBSCOhost, https://doi.org/10.1177/1120672119898414.

APA

Panos, G. D., Arruti, N., & Patra, S. (2021). The long-term efficacy and safety of fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®) in diabetic macular oedema in a multi-ethnic inner-city population. European Journal of Ophthalmology, 31(2), 620–629. https://doi.org/10.1177/1120672119898414

Chicago

Panos, Georgios D, Natalia Arruti, and Sudeshna Patra. 2021. “The Long-Term Efficacy and Safety of Fluocinolone Acetonide Intravitreal Implant 190 Μg (ILUVIEN®) in Diabetic Macular Oedema in a Multi-Ethnic Inner-City Population.” European Journal of Ophthalmology 31 (2): 620–29. doi:10.1177/1120672119898414.